RARA CRAFT DATABASE for FDA Medical Devices
510(k)K180455

FDA DEVICE FACTS

NeuralBot

Neural Analytics, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMay 22, 2018PRODUCT CODEIYN

Indications for use

The NeuralBot when used with Lucid M1 System is a medical ultrasound device which assists the user in the setup and acquisition of cerebral blood flow velocity via the patient’s temporal windows. It is intended for use as an adjunct to standard clinical practices for measuring and displaying cerebral blood flow velocity and the occurrence of transient emboli within the blood stream.

The NeuralBot is intended to be used by healthcare professionals qualified by training in its safe and effective use. The device is not intended to replace other means of evaluating vital patient physiological processes, is not intended to be used in fetal applications, and is not intended to be used inside the sterile field.

Equivalence Discussion: The NeuralBot System and Lucid M1 System (K160442): A full comparison of the technological characteristics of the NeuralBot System when connected to the Lucid M1 System and the Lucid M1 System was made. Both are TCD ultrasound flow systems with monitoring functions. Both systems monitor cerebral blood flow velocity and the occurrence of transient emboli within the blood stream via the temporal windows.

Both systems have equivalent modes and use pulsed wave Doppler (PWD) using color M- Mode for location of the vessel of interest. Additionally, both devices:

• Are transcranial Doppler ultrasound systems used for cerebral blood flow analysis

• Monitor the cerebral blood flow velocity and the occurrence of transient emboli within the blood stream via the temporal windows

• Utilize two transducers which are attached via a headset for cephalic monitoring

• Use substantially equivalent operating modes

• Measure equivalent hemodynamic indices

• Have equivalent monitoring functions

• Transducers are substantially equivalent

• Are manufactured to meet applicable physical, mechanical, and electrical safety requirements

• Display TIC, velocity spectrum, M-Mode, velocity envelope, Mean velocity, Minimum velocity, Maximum velocity, Pulsatility index, and emboli count (in emboli and bubble exams of the Lucid M1 System) NeuralBot System NeuralBot System Premarket Notification 510(k) - Volume 002, Document 004

The NeuralBot System and the Transcranial Doppler with Robotic Probe Headband, EMS- 9UA (K122710): A full comparison of the technological characteristics of the NeuralBot System when connected to the Lucid M1 System and the Transcranial Doppler with Robotic Headband was made. Both are Robotic Probe systems intended for obtaining the information of CBFV by using a non-invasive ultrasonic technique. This method of measurement is particularly useful for examining the major arteries supplying blood to the brain via the temporal window.

Both systems have equivalent modes and use pulsed wave Doppler (PWD) using color M-Mode for location of the vessel of interest. Both systems can automatically adjust the position of the ultrasonic transducers during monitoring according to the signal intensity of CBFV via the patient’s temporal windows.

Summary of Non-Clinical Testing and Reliance on Standards The NeuralBot System when used with the Lucid M1 system is evaluated for acoustic output, biocompatibility, and accuracy, as well as thermal, electrical, electromagnetic, and mechanical safety. Non-clinical testing to support thermal, mechanical, electromagnetic, and mechanical safety is conducted per the FDA Guidance Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers, using applicable sections of the following voluntary standards:

• IEC 60601-1:2012 Medical electrical equipment - Part 1: General requirements for basic safety and essential performance, Edition 3.1

• IEC 60601-1-2:2014 Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral Standard: Electromagnetic disturbances - Requirements and tests, Edition 3.1

• IEC 60601-2-37:2015 Medical electrical equipment - Part 2-37: Particular requirements for the basic safety and essential performance of ultrasonic medical diagnostic and monitoring equipment, Edition 2.1

• NEMA Standards Publication UD 2-2004(R2009) Acoustic Output Measurement Standard For Diagnostic Ultrasound Equipment Revision 3

• NEMA Standards Publication UD 3-2004(R2009) Standard for Real-Time Display of Thermal and Mechanical Acoustic Output Indices on Diagnostic Ultrasound Equipment Revision 2

• ISO 10993-1:2010 Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process, Fourth Edition NeuralBot System NeuralBot System Premarket Notification 510(k) - Volume 002, Document 004

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 27, 2026